• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有家族史的银屑病患者的临床特征:一项多中心观察性研究。

Clinical characteristics of patients with psoriasis with family history: A multicenter observational study.

机构信息

Department of Dermatology, Osaka General Medicine Center, Osaka, Japan.

Social/Community Medicine and Health Science, Graduate School of Medicine Kobe University, Kobe, Japan.

出版信息

J Dermatol. 2023 Jun;50(6):746-752. doi: 10.1111/1346-8138.16733. Epub 2023 Jan 24.

DOI:10.1111/1346-8138.16733
PMID:
36694440
Abstract

Previous studies on family history of psoriasis showed that patients with a family history have an earlier onset of the disease, but such studies in Japan are still limited. To elucidate the characteristics of patients with familial psoriasis, we studied the family history of patients with psoriasis using the West Japan Psoriasis Registry, a multi-institutional registry operated by 26 facilities in the western part of Japan, including university hospitals, community hospitals, and clinics. This study enrolled 1847 patients registered between September 2019 and December 2021, with 199 (10.8%) having a family history of psoriasis. Patients with a family history of psoriasis had significantly earlier onset of the disease than those without a family history. Furthermore, patients with a family history of psoriasis had significantly longer disease duration. Psoriatic arthritis (PsA) was significantly more common in patients with a family history (69/199, 34.7%) than in those without a family history (439/1648, 26.6%) (adjusted P = 0.023). A subanalysis of patients with PsA revealed a significant difference in the patient global assessment (PaGA) score in Fisher's exact test and adjusted test. The numbers of patients with PaGA 0/1 were 29 (43.3%) and 172 (39.9%) in patients with PsA with and without family history of psoriasis, respectively, whereas the numbers of patients with PaGA 3/4 were 13 (19.4%) and 145 (33.6%) in patients with PsA with and without family history of psoriasis, respectively. Other disease severity variables did not show a difference between the two groups. Our findings suggest that genetics play a larger role in the development of PsA than in the development of psoriasis vulgaris. Most cases of PsA occur in patients who already have psoriasis, therefore dermatologists should pay attention to joint symptoms, especially in patients with psoriasis who have a family history of psoriasis.

摘要

先前关于银屑病家族史的研究表明,有家族史的患者发病更早,但在日本此类研究仍然有限。为了阐明家族性银屑病患者的特征,我们利用日本西部的 26 家医疗机构(包括大学医院、社区医院和诊所)运营的多机构登记处——西日本银屑病登记处,对银屑病患者的家族史进行了研究。这项研究纳入了 1847 名于 2019 年 9 月至 2021 年 12 月期间登记的患者,其中 199 名(10.8%)有银屑病家族史。有银屑病家族史的患者发病明显更早,且疾病持续时间明显更长。有家族史的患者中银屑病关节炎(PsA)更为常见(69/199,34.7%),而无家族史的患者中银屑病关节炎(439/1648,26.6%)则相对较少(调整后的 P=0.023)。在对有银屑病关节炎的患者进行的亚分析中,Fisher 确切检验和调整检验均显示患者总体评估(PaGA)评分存在显著差异。在有和无银屑病家族史的银屑病关节炎患者中,PaGA 0/1 的患者分别有 29 名(43.3%)和 172 名(39.9%),而 PaGA 3/4 的患者分别有 13 名(19.4%)和 145 名(33.6%)。两组之间其他疾病严重程度变量没有差异。我们的研究结果表明,遗传因素在银屑病关节炎的发生中比在寻常型银屑病的发生中起更大的作用。大多数银屑病关节炎发生在已有银屑病的患者中,因此皮肤科医生应注意关节症状,尤其是在有银屑病家族史的银屑病患者中。

相似文献

1
Clinical characteristics of patients with psoriasis with family history: A multicenter observational study.有家族史的银屑病患者的临床特征:一项多中心观察性研究。
J Dermatol. 2023 Jun;50(6):746-752. doi: 10.1111/1346-8138.16733. Epub 2023 Jan 24.
2
Associations between family history of psoriatic disease and clinical characteristics on patients with psoriatic arthritis: a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR II).银屑病关节炎患者的银屑病家族史与临床特征的相关性:来自中国银屑病关节炎注册研究(CREPAR II)的全国性研究。
Clin Exp Rheumatol. 2023 Sep;41(9):1901-1907. doi: 10.55563/clinexprheumatol/gbg5i5. Epub 2023 May 15.
3
Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease.银屑病或银屑病关节炎家族史对银屑病疾病的影响。
Arthritis Care Res (Hoboken). 2020 Jan;72(1):63-68. doi: 10.1002/acr.23836.
4
Prevalence of Psoriatic Arthritis in Nagano Prefecture, Japan, and Efficacy of the Psoriasis Epidemiology Screening Tool: A Real-World Survey.日本长野县银屑病关节炎的流行情况及银屑病流行病学筛查工具的疗效:一项真实世界调查。
Tohoku J Exp Med. 2022 Jun 25;257(3):205-210. doi: 10.1620/tjem.2022.J035. Epub 2022 Apr 28.
5
Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting.拉丁美洲银屑病和银屑病关节炎的全球合作机会和挑战:GRAPPA 2010 年会报告。
J Rheumatol. 2012 Feb;39(2):445-7. doi: 10.3899/jrheum.111246.
6
Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.银屑病患者的管理:银屑病患者中银屑病关节炎的诊断和药物治疗。
Drugs. 2014 Mar;74(4):423-41. doi: 10.1007/s40265-014-0191-y.
7
Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry.从 REGISPONSER 登记处比较银屑病关节炎和强直性脊柱炎伴银屑病患者的轴向表型:一项研究。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002513.
8
Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database.银屑病关节炎患者的疾病特征可能因银屑病发病年龄而异:来自银屑病关节炎国际数据库的横断面数据。
Clin Exp Rheumatol. 2021 May-Jun;39(3):532-536. doi: 10.55563/clinexprheumatol/ert0p7. Epub 2020 Jun 30.
9
High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study.银屑病患者中银屑病关节炎的高患病率:一项横断面研究。
Rheumatol Int. 2014 Feb;34(2):227-34. doi: 10.1007/s00296-013-2876-z. Epub 2013 Oct 10.
10
Early psoriatic arthritis in Japan: Post-hoc analyses from a survey by the Japanese Society of Psoriasis Research.日本的早期银屑病关节炎:日本银屑病研究学会调查的事后分析。
J Dermatol. 2021 Jun;48(6):902-906. doi: 10.1111/1346-8138.15924. Epub 2021 Apr 25.

引用本文的文献

1
Advancements in understanding and treating psoriasis: a comprehensive review of pathophysiology, diagnosis, and therapeutic approaches.银屑病理解与治疗的进展:病理生理学、诊断及治疗方法的全面综述
PeerJ. 2025 Apr 29;13:e19325. doi: 10.7717/peerj.19325. eCollection 2025.
2
Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen.银屑病的局部治疗:临床益处、新型药物递送策略的进展及基因治疗方案
Pharmaceutics. 2025 Feb 20;17(3):283. doi: 10.3390/pharmaceutics17030283.
3
The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study.
家族史对银屑病患者临床表现及生物治疗反应的影响:一项多中心前瞻性队列研究
Am J Clin Dermatol. 2025 Mar;26(2):291-300. doi: 10.1007/s40257-025-00918-y. Epub 2025 Jan 22.
4
Parental Consanguinity and Family History in Relation to Psoriasis and the Role of Sex: A Case-Control Study.与银屑病相关的父母近亲结婚及家族史以及性别的作用:一项病例对照研究
Hum Hered. 2025;90(1):1-9. doi: 10.1159/000543351. Epub 2024 Dec 31.
5
Clinical characteristics of patients with a family history of psoriasis: an observational epidemiological study in Chinese Han population.有银屑病家族史患者的临床特征:一项针对中国汉族人群的观察性流行病学研究。
Front Med (Lausanne). 2024 Aug 16;11:1455953. doi: 10.3389/fmed.2024.1455953. eCollection 2024.
6
Factors associated with a better treatment efficacy among psoriasis patients: a study based on decision tree model and logistic regression in Shanghai, China.与银屑病患者治疗效果更好相关的因素:基于决策树模型和 logistic 回归的在中国上海开展的研究。
BMC Public Health. 2024 Jul 18;24(1):1934. doi: 10.1186/s12889-024-19468-9.
7
Genome‑wide association study and polygenic risk scores predict psoriasis and its shared phenotypes in Taiwan.全基因组关联研究和多基因风险评分预测台湾的银屑病及其共享表型。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13239. Epub 2024 May 17.
8
Systemic therapy for psoriasis and the risk of cutaneous infections.银屑病的系统治疗与皮肤感染风险。
J Dermatol. 2024 Jul;51(7):939-949. doi: 10.1111/1346-8138.17245. Epub 2024 Apr 25.
9
Relationship Between Family History and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study from China.银屑病患者家族史与生活质量的关系:一项来自中国的横断面研究。
Clin Cosmet Investig Dermatol. 2024 Apr 20;17:891-900. doi: 10.2147/CCID.S453078. eCollection 2024.